Switching to Omnitrope® from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study...
Switching to Omnitrope® from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
About this item
Full title
Author / Creator
Publisher
Heidelberg: Springer Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
Heidelberg: Springer Healthcare
Subjects
More information
Scope and Contents
Contents
Introduction
This study was conducted using an integrated retrospective database to evaluate the effectiveness of Omnitrope
®
(Sandoz) on children with growth hormone deficiency (GHD), idiopathic short stature (ISS), and Turner Syndrome (TS) who switched from a non-Omnitrope recombinant human growth hormone (rhGH) preparation during routin...
Alternative Titles
Full title
Switching to Omnitrope® from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4254867
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4254867
Other Identifiers
ISSN
2195-5840
E-ISSN
2190-9164
DOI
10.1007/s13554-014-0017-1
